Assessment of quality of life in patients with cervical dystonia and hemifacial spasm after botulinum toxin injections

IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Acta neurologica Belgica Pub Date : 2025-02-24 DOI:10.1007/s13760-025-02742-x
Haidy Elshebawy, Gihan M. Ramzy, Mohammed Salama, Shaimaa El-Jaafary
{"title":"Assessment of quality of life in patients with cervical dystonia and hemifacial spasm after botulinum toxin injections","authors":"Haidy Elshebawy,&nbsp;Gihan M. Ramzy,&nbsp;Mohammed Salama,&nbsp;Shaimaa El-Jaafary","doi":"10.1007/s13760-025-02742-x","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Botulinum toxin is now used to treat a variety of neurological and non-neurological disorders. Despite the fact that injections of botulinum neurotoxin may significantly reduce the involuntary muscular contractions associated with focal dystonia and hemifacial spasm (HFS), it is less certain whether the motor effect would result in an improvement in health-related quality of life (HR-QoL).Our goal was to evaluate how botulinum toxin affected individuals with cervical dystonia and hemifacial spasm in terms of their quality of life, self-esteem, pain, sleep, and depression.</p><h3>Methods</h3><p>This is a prospective study that included 40 patients diagnosed with cervical dystonia or hemifacial spasm treated with Botulinum toxin. Quality of life, self-esteem, pain, sleep and depression were all assessed in the studied patients by self-reporting questionnaires to assess the impact of botulinum toxin on them.</p><h3>Results</h3><p>The quality of life with its components (physical, physical role, emotional role, vitality, mental health, social functioning and pain) showed significant improvement at the end of follow up compared to baseline with p values ≤ 0.001. Also, there was a significant improvement of self-esteem score, depression score, at the end of follow up period compared to baseline assessment with p value 0.012, &lt; 0.001 respectively. Moreover, there was a significant improvement of all pain scales and sleep quality scores with p values &lt; 0.05 except the habitual sleep efficiency.</p><h3>Conclusion</h3><p>botulinum toxin is an effective therapy for motor and non-motor manifestations associated with focal cervical dystonia and hemifacial spasm as well as the quality of life and to conclude that its effectiveness is dependent not only on the elimination of physical symptoms, but also on improving the patients’ and their families’ emotional and social status to help providing the drug to all eligible patients.</p></div>","PeriodicalId":7042,"journal":{"name":"Acta neurologica Belgica","volume":"125 3","pages":"707 - 716"},"PeriodicalIF":2.1000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta neurologica Belgica","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s13760-025-02742-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Botulinum toxin is now used to treat a variety of neurological and non-neurological disorders. Despite the fact that injections of botulinum neurotoxin may significantly reduce the involuntary muscular contractions associated with focal dystonia and hemifacial spasm (HFS), it is less certain whether the motor effect would result in an improvement in health-related quality of life (HR-QoL).Our goal was to evaluate how botulinum toxin affected individuals with cervical dystonia and hemifacial spasm in terms of their quality of life, self-esteem, pain, sleep, and depression.

Methods

This is a prospective study that included 40 patients diagnosed with cervical dystonia or hemifacial spasm treated with Botulinum toxin. Quality of life, self-esteem, pain, sleep and depression were all assessed in the studied patients by self-reporting questionnaires to assess the impact of botulinum toxin on them.

Results

The quality of life with its components (physical, physical role, emotional role, vitality, mental health, social functioning and pain) showed significant improvement at the end of follow up compared to baseline with p values ≤ 0.001. Also, there was a significant improvement of self-esteem score, depression score, at the end of follow up period compared to baseline assessment with p value 0.012, < 0.001 respectively. Moreover, there was a significant improvement of all pain scales and sleep quality scores with p values < 0.05 except the habitual sleep efficiency.

Conclusion

botulinum toxin is an effective therapy for motor and non-motor manifestations associated with focal cervical dystonia and hemifacial spasm as well as the quality of life and to conclude that its effectiveness is dependent not only on the elimination of physical symptoms, but also on improving the patients’ and their families’ emotional and social status to help providing the drug to all eligible patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
注射肉毒杆菌毒素后颈肌张力障碍和面肌痉挛患者的生活质量评价。
背景:目前,肉毒杆菌毒素已被用于治疗多种神经系统和非神经系统疾病。尽管注射肉毒杆菌神经毒素可以显著减少与局灶性肌张力障碍和半面痉挛(HFS)相关的肌肉不自主收缩,但运动效应是否会导致与健康相关的生活质量(HR-QoL)的改善还不太确定。我们的目标是评估肉毒杆菌毒素如何影响颈肌张力障碍和半面痉挛患者的生活质量、自尊、疼痛、睡眠和抑郁:这是一项前瞻性研究,纳入了 40 名接受肉毒杆菌毒素治疗的颈肌张力障碍或半面痉挛患者。研究人员通过自我报告问卷对患者的生活质量、自尊、疼痛、睡眠和抑郁进行了评估,以评估肉毒杆菌毒素对他们的影响:结果:与基线相比,随访结束时的生活质量及其组成部分(身体、身体角色、情感角色、活力、心理健康、社会功能和疼痛)均有明显改善,P值≤0.001。结论:肉毒杆菌毒素是治疗局灶性颈肌张力障碍和面肌痉挛相关运动和非运动表现以及生活质量的有效疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta neurologica Belgica
Acta neurologica Belgica 医学-临床神经学
CiteScore
4.20
自引率
3.70%
发文量
300
审稿时长
6-12 weeks
期刊介绍: Peer-reviewed and published quarterly, Acta Neurologica Belgicapresents original articles in the clinical and basic neurosciences, and also reports the proceedings and the abstracts of the scientific meetings of the different partner societies. The contents include commentaries, editorials, review articles, case reports, neuro-images of interest, book reviews and letters to the editor. Acta Neurologica Belgica is the official journal of the following national societies: Belgian Neurological Society Belgian Society for Neuroscience Belgian Society of Clinical Neurophysiology Belgian Pediatric Neurology Society Belgian Study Group of Multiple Sclerosis Belgian Stroke Council Belgian Headache Society Belgian Study Group of Neuropathology
期刊最新文献
A cross-sectional study of autonomic dysfunction in patients with Parkinson's disease and vascular parkinsonism. The effect of botulinum neurotoxin injection on non-motor symptoms of cervical dystonia: A prospective cohort. Rapidly progressive motor neuron syndrome with onset ten years after severe brain trauma: case report and literature review. A case of relapsing NMOSD initially mimicking radiation myelopathy‌: diagnostic challenge and eculizumab add-on therapy. Nummular eczema onset in an AQP4-IgG-positive NMOSD patient treated with ravulizumab.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1